Nanocrystalline titanium dioxide and magnesium oxide in vitro dermal absorption in human skin

Cutan Ocul Toxicol. 2009;28(2):78-82. doi: 10.1080/15569520902914926.

Abstract

The dermal absorption potential of a nanocrystalline magnesium oxide (MgO) and titanium dioxide (TiO(2)) mixture in dermatomed human skin was assessed in vitro using Bronaugh-type flow-through diffusion cells. Nanocrystalline material was applied to the skin surface at a dose rate of 50 mg/cm(2) as a dry powder, as a water suspension, and as a water/surfactant (sodium lauryl sulfate) suspension, for 8 hours. Dermal absorption of nanocrystalline MgO and TiO(2) through human skin with intact, functional stratum corneum was not detectable under the conditions of this experiment.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Administration, Topical
  • Adult
  • Diffusion Chambers, Culture
  • Humans
  • In Vitro Techniques
  • Magnesium Oxide / administration & dosage
  • Magnesium Oxide / blood
  • Magnesium Oxide / chemistry
  • Magnesium Oxide / pharmacokinetics*
  • Magnesium Oxide / toxicity
  • Microscopy, Electron, Transmission
  • Models, Biological
  • Nanoparticles*
  • Skin / drug effects*
  • Skin / metabolism
  • Skin / ultrastructure
  • Skin Absorption*
  • Titanium / administration & dosage
  • Titanium / blood
  • Titanium / chemistry
  • Titanium / pharmacokinetics*
  • Titanium / toxicity

Substances

  • titanium dioxide
  • Magnesium Oxide
  • Titanium